Op-eds: Canadian and American regulators, law enforcement and patient advocates oppose drug importation

Since 2000, every head of the United States Food and Drug Administration (FDA) and United States Department of Health and Human Services (HHS) has opposed drug importation because the benefits that might be gained are far outweighed by the many dangers. Law enforcement, patient advocates, pharmacy groups, and regulators agree.

Chairman and Editor In Chief Warns That Allowing Drug Importation Is All Risk And No Reward

Oct 10, 2018

In this October 10, 2018 editorial for The Hill, publishing executive warns that America has nothing to gain and everything to lose if we forsake our secure drug supply chain for allowing the importation of dangerous drugs…

President Of Nonprofit Warns That Allowing Foreign Drug Importation Is A Threat To U.S. Patients

Sep 18, 2018

In this September 17, 2018, editorial for The Detroit News, the Center for Medicine in the Public Interest’s President and co-founder Peter Pitts warned that legalizing prescription drug importation will not generate massive savings for U.S. citizens while also potentially exposing millions of Americans to dangerous counterfeit drugs…

Importation Has Some Huge Risks

Sep 5, 2018

There are certainly things we can learn from other countries’ healthcare successes, but importation is not the right approach.

Discussing the Difficulty of the Import Problem

Sep 4, 2018

This distressing situation shows that deadly fentanyl analogues are killing Americans who are using laced non-opioid prescriptions.

Canadian Law Enforcement Veteran Urges Cross-Border Cooperation to Fight Fentanyl and Other Counterfeit Medicines

Aug 29, 2018

In this August 21, 2018 editorial for the Havre Daily News Canada Border Services Agency and the Ontario Provincial Police veteran Don Bell talks about the need for Canada and the United States to work together to combat counterfeit drugs.

National Sheriffs’ Association Sends Letter of Concern About Importation of Prescription Drugs

Aug 29, 2018

On August 8, 2018, the National Sheriffs’ Association wrote the President to oppose prescription drug importation. Importing drugs from other countries, they say, “jeopardizes law enforcement’s ability to protect the public health and endangers the safety of law enforcement and other first responders.”

Drug Importation is Fraught with Peril

Aug 23, 2018

As a licensed pharmacist, I’m all too familiar with patients’ difficulties getting medications they need and their physician has prescribed. As baby boomers age, pharmacists see more patients at our counters unable to obtain needed treatments for heart disease, high blood pressure, diabetes, and other chronic illnesses. This issue is now being acknowledged and a healthy debate has begun over possible solutions. But one idea policymakers shouldn’t pursue is opening up our country’s secure drug supply to medicines coming from outside our borders.

Canada must guard against unrestricted drug exports to the US

Aug 14, 2018

The impact on Canada’s health care system could be devastating. In the aftermath of a previous American proposal, a 2010 study on the potential effects of exporting Canada’s drug supply to the US concluded that “if 10% of the US prescriptions were filled from Canadian sources (manufacturer, wholesale or retail), Canada’s 2007 drug supply would be exhausted in 224 days.”

A 2018 follow-up study reached similar conclusions. Such studies are all but ignored by US clinicians who urge importing drugs from Canada, and who are strangely oblivious to the fact that supplying an American patient could mean taking that same drug away from someone who needs it in Canada.

Talk Radio Host Reminds Americans that Drug Reimportation Poses Real Risks

Aug 10, 2018

In this August 9, 2018 editorial for RealClearMarkets, Bill Martinez reminds Americans that the FDA hasn’t yet approved importation for a reason: it’s impossible to open the floodgates to foreign drug imports without cutting corners on safety.

Proposed Changes to WHOIS system privacy will help hide internet criminals, NABP director warns

Aug 3, 2018

In this August 1, 2018 editorial for Inside Sources, National Association of Boards of Pharmacy Director Carmen Catizone raises the alarm about ICANN’s proposed changes to the WHOIS system, a database that identifies the owners of web domains. These changes are meant to bring WHOIS in compliance with new European privacy laws but, he warns, they would also impede law enforcement and others’ efforts to “connect the dots and link up different websites run as part of large criminal enterprises” like drug counterfeiting rings.